Overview
Lung-yi Mak practices in Hong Kong, China. Mak is rated as an Elite expert by MediFind in the treatment of Hepatitis. Their top areas of expertise are Hepatitis B, Hepatitis, Non-Alcoholic Fatty Liver Disease, Liver Cancer, and Liver Transplant.
Their clinical research consists of co-authoring 152 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 100 articles in the study of Hepatitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- HepatitisMak isElite. Learn about Hepatitis.
- Hepatitis BMak isElite. Learn about Hepatitis B.
- Distinguished
- Liver CancerMak isDistinguished. Learn about Liver Cancer.
- Non-Alcoholic Fatty Liver Disease
- Advanced
- CirrhosisMak isAdvanced. Learn about Cirrhosis.
- Experienced
- ColitisMak isExperienced. Learn about Colitis.
- Crohn's DiseaseMak isExperienced. Learn about Crohn's Disease.
- Gallbladder DiseaseMak isExperienced. Learn about Gallbladder Disease.
- GallstonesMak isExperienced. Learn about Gallstones.
- Hemorrhagic ProctocolitisMak isExperienced. Learn about Hemorrhagic Proctocolitis.
- Hepatitis CMak isExperienced. Learn about Hepatitis C.